Article

MAPK Pathway Inhibition as A Rational Therapeutic Strategy for MiR-138-5p/PAQR3 Dysregulation-mediated Epirubicin Resistance in Triple-negative Breast Cancer

2021-02-28

Abstract excerpt

Anthracyclines, such as epirubicin, activate the mitogen-activated protein kinase (MAPK) pathway in breast cancer (BC). Better predictors of tumor response are needed to guide de-intensification of anthracyclines when used in BC treatment. Here, we aimed to see if MAPK activation was responsible and targetable for epirubicin resistance, and to explore mechanisms and predictive markers for resistance. MAPK pathway...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 692a73b3-9b34-5d96-ba96-0b8cf511ded2
DOI: 10.1101/2021.02.28.433242

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

MAPK Pathway Inhibition as A Rational Therapeutic Strategy for MiR-138-5p/PAQR3 Dysregulation-mediated Epirubicin Resistance in Triple-negative Breast CancerDOI 10.1101/2021.02.28.433242Read

Targeting the MAPK signaling pathway: implications and prospects of flavonoids in 3P medicine as modulators of cancer cell plasticity and therapeutic resistance in breast cancer patientsSemantic proximity Read

Rationale for targeting the Ras/MAPK pathway in triple-negative breast cancer.Semantic proximity Read

Subpathway Analysis of Transcriptome Profiles Reveals New Molecular Mechanisms of Acquired Chemotherapy Resistance in Breast CancerSemantic proximity Read

PAQR3 expression is downregulated in human breast cancers and correlated with HER2 expressionSemantic proximity Read

Quantitative Tyr Phosphoproteomic Analyses Identify Cholesterol as a Master Regulator of the Tumor Adaptive Resistance to MAPK InhibitionSemantic proximity Read

Targeting MAPK Signaling in Cancer: Mechanisms of Drug Resistance and SensitivitySemantic proximity Read

The miR-362-3p/ <i>BCLAF1</i> axis regulates cisplatin sensitivity and metastatic progression in triple-negative breast cancerSemantic proximity Read

The integration of multidisciplinary approaches revealed PTGES3 as a novel drug target for breast cancer treatmentSemantic proximity Read

Molecular Pathways: PI3K Pathway Targets in Triple-Negative Breast CancersSemantic proximity Read

Crosstalk between miRNAs and signaling pathways in the development of drug resistance in breast cancerSemantic proximity Read

A Novel Approach to Classifying Chemotherapeutic Agents Based on Their Impact on Canonical Pathways: Implications for Overcoming Multidrug Resistance in Breast CancerSemantic proximity Read

Targeting MAPK in Cancer 2.0Semantic proximity Read